Biocon Limited
BIOCON
Peringkat dalam Saham
#3433
Biocon Limited functions as a biopharmaceutical firm, engaged in the production... Biocon Limited functions as a biopharmaceutical firm, engaged in the production of pharmaceutical, medicinal chemical, and plant-derived products. Its business activities are organized into distinct segments: Generics, Novel Biologics, Biosimilars, and Research Services. The company dedicates its efforts to crucial therapeutic domains, including diabetes, oncology, immunology, ophthalmology, and bone health disorders. Furthermore, Biocon provides comprehensive services encompassing the discovery, development, and manufacturing of both small and large molecules. With a wide international presence, it caters to customers in roughly 120 nations. Headquartered in Bengaluru, India, Biocon Limited commenced operations in 1978.
Harga Saham
$3.69
Kapitalisasi Pasar
$5.04B
Perubahan (1 hari)
-1.76%
Perubahan (1 tahun)
-11.38%
Negara
IN
Perdagangan Biocon Limited (BIOCON)
Kategori
Healthcare
Pendapatan untuk Biocon Limited (BIOCON)
Pendapatan pada Jun 2026 TTM: $1.91B
Menurut laporan keuangan terbaru dari Biocon Limited, pendapatan saat ini (TTM) adalah $1.91B. Pada tahun 2024, perusahaan menghasilkan pendapatan sebesar $1.77B peningkatan dibandingkan pendapatan pada tahun 2023 yang sebesar $1.36B. Pendapatan adalah jumlah total yang dihasilkan dari penjualan barang atau jasa. Tidak seperti laba, tidak ada pengeluaran yang dikurangkan.
Riwayat pendapatan Biocon Limited dari 2004 hingga 2026
Pendapatan pada akhir setiap tahun
| Tahun | Pendapatan | Mengubah |
|---|---|---|
| 2026 (TTM) | $1.91B | 6.92% |
| 2025 | $1.78B | 0.84% |
| 2024 | $1.77B | 30.15% |
| 2023 | $1.36B | 26.12% |
| 2022 | $1.08B | 10.49% |
| 2021 | $975.78M | 16.67% |
| 2020 | $836.33M | 5.32% |
| 2019 | $794.12M | 25.39% |
| 2018 | $633.30M | 5.55% |
| 2017 | $600.02M | 18.75% |
| 2016 | $505.27M | 2.04% |
| 2015 | $495.17M | -3.94% |
| 2014 | $515.48M | 12.70% |
| 2013 | $457.40M | 13.20% |
| 2012 | $404.08M | -21.72% |
| 2011 | $516.22M | 13.85% |
| 2010 | $453.41M | 67.79% |
| 2009 | $270.22M | 29.75% |
| 2008 | $208.27M | 9.73% |
| 2007 | $189.80M | 22.96% |
| 2006 | $154.36M | 4.28% |
| 2005 | $148.03M | 28.03% |
| 2004 | $115.62M | 0.00% |
Pendapatan untuk perusahaan serupa atau pesaing
| Perusahaan | Pendapatan | Perbedaan Pendapatan | Negara |
|---|---|---|---|
| $12.62B | 561.69% |
US
|
|
| $2.23B | 16.78% |
US
|
|
| $15.74B | 725.22% |
AU
|
|
| - | - |
CH
|
|
| $6.02B | 215.60% |
NL
|
